Frequently Asked Questions on the Management of mCRC

More details
Frequently Asked Questions on the Management of mCRC

Past Events

Register now

The Power of Precision Medicine in Advanced Non-Small Cell Lung Cancer: Focus on Targeting MET Alterations

The Power of Precision Medicine in Advanced Non-Small Cell Lung Cancer: Focus on Targeting MET Alterations

In the era of precision medicine, detecting genomic alterations is the first priority and guiding principle for personalized care. Advances in molecular...

Frequently Asked Questions on Managing NSCLC With Rare Oncogenic Drivers

Frequently Asked Questions on Managing NSCLC With Rare Oncogenic Drivers

The field of lung cancer is changing rapidly. The use of molecular testing and targeted therapy in oncogene-driven non-small cell lung cancer...

Managing Recurrent SCCHN in the Era of Immunotherapy:<br>Opportunities and Hurdles in Daily Clinical Practice

Managing Recurrent SCCHN in the Era of Immunotherapy:
Opportunities and Hurdles in Daily Clinical Practice

The management of recurrent/metastatic (R/M) squamous cell cancer of the head and neck (SCCHN) is evolving rapidly, and physicians often face clinical...

Virtual Molecular Tumor Board on Metastatic Colorectal Cancer:                Expert Advice on Managing Challenging Cases

Virtual Molecular Tumor Board on Metastatic Colorectal Cancer: Expert Advice on Managing Challenging Cases

The treatment landscape of metastatic colorectal cancer (mCRC) is changing rapidly. Advances in the molecular characterization of mCRC and increasing numbers of precision medicine...

Hot Topics in the Management of Advanced Non-Small Cell Lung Cancer:<br>Expert Insights on Recent Advances

Hot Topics in the Management of Advanced Non-Small Cell Lung Cancer:
Expert Insights on Recent Advances

The management of advanced non-small cell lung cancer (NSCLC) is changing rapidly, with advances in genomic testing, new precision medicines, and innovative...

Integration of New Biomarkers and <br>Targeted Therapy in Advanced NSCLC:<br> Challenges and Solutions

Integration of New Biomarkers and
Targeted Therapy in Advanced NSCLC:
Challenges and Solutions

The treatment landscape for oncogene-driven advanced non-small cell lung cancer (NSCLC) is changing rapidly. The introduction of novel molecular targeted therapies against...